Geetha P. Bansal

New use of BCG for recombinant vaccines

C. Kendall Stover, Vidal F. de la Cruz, Thomas R. Fuerst et al. · Nature · 1991 · 1.5K citations · Full text

Vaccination, Vaccinology, Vaccine Development +5

Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus

Syd Johnson, Cynthia N. Oliver, Gregory A. Prince et al. · The Journal of Infectious Diseases · 1997 · 636 citations · Full text

Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.

C. Kendall Stover, Geetha P. Bansal, Mark S. Hanson et al. · The Journal of Experimental Medicine · 1993 · 268 citations · Full text

Vaccine Research, Microbial Pathogens, Humoral Response +23

Candidate Recombinant Vaccine for Human B19 Parvovirus

Geetha P. Bansal, Jeanine Hatfield, Frances Dunn et al. · The Journal of Infectious Diseases · 1993 · 134 citations

Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.

Stephen J. Rosenfeld, Kohji Yoshimoto, Sachiko Kajigaya et al. · Journal of Clinical Investigation · 1992 · 108 citations · Full text

Unique Region, Virus Structure, Virion Surface +14